Evaluation of the anesthetic effect and safety of Ciprofol combined with low-dose fentanyl in painless gastrointestinal endoscopy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063410

Enrollment

Unknown

Registered

2022-09-06

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic gastrointestinal diseases

Interventions

Ciprofol group:Ciprofol combined with low-dose fentanyl

Propofol group:Propofol combined with low-dose fentanyl

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. No cognitive impairment; 3. No severe cardiopulmonary disease; 4. Cardiac function grade II-III.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
SpO2;hemodynamics;recovery time;adverse reaction;leave hospital time;Incidence of respiratory depression; patient satisfaction;;	—

Countries

China

Contacts

Public ContactLini Chen

The Second Affiliated Hospital of Guangxi Medical University

9906898932@qq.com+86 18070927318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026